Inflammatory pseudotumor

Inflammatory pseudotumor is a benign condition characterized by a mass-like lesion that mimics a malignant tumor both clinically and radiologically. It can occur in various parts of the body, but is most commonly found in the lungs and orbit. The exact cause of inflammatory pseudotumor is unknown, but it is thought to be related to an abnormal response to injury or infection.

Etiology

The exact cause of inflammatory pseudotumor is unknown. Some researchers believe it may be related to an abnormal response to injury or infection. Others suggest it may be an autoimmune disorder. Autoimmune disorders are conditions in which the body's immune system mistakenly attacks its own tissues.

Symptoms

The symptoms of inflammatory pseudotumor can vary depending on the location of the tumor. Common symptoms may include pain, swelling, and a palpable mass. If the tumor is in the lungs, symptoms may include cough, shortness of breath, and chest pain. If the tumor is in the orbit, symptoms may include proptosis (bulging of the eye), decreased vision, and eye pain.

Diagnosis

Diagnosis of inflammatory pseudotumor can be challenging due to its nonspecific symptoms and its similarity to malignant tumors on imaging studies. A biopsy is often needed to confirm the diagnosis. The biopsy will show a mass of inflammatory cells, including lymphocytes, plasma cells, and histiocytes, but no malignant cells.

Treatment

Treatment of inflammatory pseudotumor depends on the location and size of the tumor, as well as the patient's overall health. Treatment options may include surgery, radiation therapy, and medications to reduce inflammation, such as corticosteroids. In some cases, no treatment is needed and the tumor will resolve on its own.

Prognosis

The prognosis for inflammatory pseudotumor is generally good. Most tumors are benign and do not spread to other parts of the body. However, the tumor can cause symptoms and complications depending on its location. In some cases, the tumor may recur after treatment.